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Abstract
BACKGROUND: The unique mechanism of dithizone action in
the interior of the viable pancreatic islet suggests the possible
development of a specific radiopharmaceutical that may have
a potential clinical application in the diagnosis of the pancreat-
ic organ allografts or islets rejection.
The radiodiagnostic properties of the newly developed radio-
active analogue of dithizone, i.e. Dithizone-[131I]-Histamine con-
jugate have been evaluated in the present study.
METHODS: The four islet cells transplantation models were
chosen for this purpose.
The most important feature of the Dithizone-[131I]-Histamine con-
jugate is the ability of zinc chelation. As was presented in the
recent study, the conjugate stains pink-reddish the isolated
pancreatic islets in vitro. Among the studied transplantation
models, only the islets grafting under testis capsule enabled
determination of the pancreatic islets in rats by radioactive Di-
thizone-[131I]-Histamine conjugate. The level of the radioactivity
in the recipient testis (right) was almost two times higher com-
pared to the controls (0.24 vs. 0.13% ID/g, respectively).
CONCLUSIONS: These preliminary data demonstrate the abil-
ity of the developed radioactive analogue of dithizone for in vivo
identification of transplanted pancreatic islets, and suggests a
potential clinical application of the radiodithizone in the diag-
nosis of the pancreatic islet rejection.
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Introduction
At present, there is no specific method available for the identifica-
tion of pancreatic islet grafts and monitoring their function. Di-
thizone, a powerful zinc chelator, applied for in vitro staining of the
viable pancreatic islet cells, has been recently proved to stain crim-
son the islets in vivo (13). These observations suggest a possi-
ble application of the radioactive analogue of dithizone for in vivo
monitoring of the transplanted islet cells survival.
Our previous study (4) has shown that the radioactive ana-
logue of dithizone (Dithizone-[131I]-Histamine conjugate, Figure1)
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could be efficiently prepared by conjugation of the carboxylic de-
rivative of dithizone (i.e. 2,2-dicarboxy dithizone) to the carrier of
iodine radioisotopes i.e. Histamine. The mixed anhydride conju-
gation technique has been applied for the amide bond formation
between the carbonyl atom of 2,2-dicarboxy dithizone and the
side chain amine group of iodohistamine. Radiochemical proper-
ties of the conjugate, as well as preliminary biodistribution in ani-
mals have been investigated previously (4).
Figure 1. Scheme of Dithizone-[131I]-Histamine Conjugate.
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Basic
Sciences
The aim of this study was to evaluate the utility of the Dithizone-
-[131I]-Histamine conjugate for survival staining of transplanted
pancreatic islets following intravenous administration.
Materials and Methods
Two radioactive analogues of dithizone, i.e. Dithizone-[125I]-
-Histamine and Dithizone-[131I]-Histamine conjugates were pre-
pared according to the procedure described previously (4) by link-
age of 2,2-dicarboxy dithizone with one form of the radioiodinat-
ed histamine i.e. 125I-Histamine or 131I-Histamine. In our studies,
we used Dithizone-[125I]-Histamine conjugate of specific activity
ASA ~ 1.92 GBq/µmol, and Dithizone-[
131I]-Histamine conjugate of
specific activity in the range from 1.7 to 2.0 GBq/µmol.
The pancreatic islets (both for in vitro and for transplantation
studies) were isolated using modified Lacy et al. method (5). Fresh
islets were isolated from WAG rats by digestion of pancreas using
collagenase P (Boehringer Mannheim, Indianapolis, IN, USA), fol-
lowed by islets purification on Ficolls (Sigma) gradient, and hand-
picking under stereomicroscope (6).
All animal experiments were approved by the Ethics Commit-
tees of the Institutes and were carried out in accordance with prin-
ciples of good laboratory practice.
In vitro staining of the isolated rats pancreatic islets
In vitro staining of the isolated pancreatic islets was investigated
using two of the Dithizone-[*I]-Histamine conjugates of a similar
specific activity (ASA ~ 1.92 and 1.85 GBq/µmol), although con-
taining different iodine isotope, i.e. I-125 and I-131, respectively.
Approximately the 1500 islets dispersed in 23 ml of Hanks bal-
ancing salt were concentrated to ca 200 islets in 1ml by centrifu-
gation and decantation. 50 ml of the radioactive conjugate (CA 5
MBq/ml) was then added to the suspension of 200 islets in 1ml
Hanks balancing salt, followed by incubation at 37oC for 10 and
30 min. The islets were isolated by centrifugation and decanta-
tion, and then they were washed with PBS solution. The washing
procedure was repeated, then the islets were transferred to clean
tubes, and the radioactivity was measured in the gamma counter.
The staining experiment was carried out in triplicate for each of
the radioactive conjugates used.
Localisation of the transplanted islets in vivo
Localisation of the transplanted islets in vivo was tested using four
models of islet cells transplantation. Rats (WAG, 250280g) were
used as donors and recipients. Diabetes was induced by intrave-
nous streptozocin injection (65 mg/kg body weight). Approximate-
ly 12001500 islets were transplanted: to liver (into the portal vein),
under kidney capsule, to mesentery and under testis capsule. Blood
glucose level was monitored daily after transplantation. The biodis-
tribution study was done within two weeks of remission of diabetes
(blood glucose level below 105110 mg%). The [131I]-radiolabelled
conjugate (0.2 ml, CA 10 MBq/ml, ASA ~ 2 GBq/µmol) was injected
intravenously to tail vein. 30-min p.i.v., the rats were anaesthetised,
and the organs were selected for radioactivity determination in gam-
ma-counter. Biodistribution of the conjugate in the transplantation
models (from 5 to 7 animals for each model) was compared to the
controls (six Wistar rats for each daily series). An unpaired Student
t-test (at 95% confidence interval) was applied for data evaluation.
Results and Discussion
The most important feature of the Dithizone-[*I]-Histamine conju-
gate is the ability of zinc chelation (4). In the present study we have
observed that most of the fresh isolated rats islets stained pink-
reddish just 10 minutes following exposure to a medium containing
the Dithizone-[*I]-Histamine solution. The colour of the stained is-
lets was similar to that observed after dithizone or di-iododhitizone
exposure (13), lasting during the washing with PBS, and while
storing at room temperature for ca 34 hrs. Additionally, the stain-
ing was accompanied by the radioactivity found (for example over
300 Bq of 125I in 200 islets). Regarding the specific activity of the
conjugate, the content of the chelated zinc(II) in the interior of the
islet cells could be estimated as ca 0.2 pmol in 200 islets, although
this calculation might have only a qualitative value.
In spite of the fact that all of the tested grafts reversed diabe-
tes in the proper time after transplantation, it seems evident that
the quantity of the transplanted islet cells was too small for its
distinct radiographic visualisation, especially in the regions of a
high activity background (liver, kidney). Among the studied trans-
plantation models, only the islets grafting under testis capsule
enabled determination of the pancreatic islets in rats by radioac-
tive Dithizone-[131I]-Histamine conjugate (Figure 2). In the cases
of other recipient organs, the activity background was too high,
and prevented the differentiation of the transplanted cells.
As presented in Figure 2, the level of the radioactivity in the recip-
ient testis (right) was almost two times higher compared to the con-
trols (0.24% – 0.05 vs. 0.13% – 0.02 ID/g, respectively, tStat = 6.66, df =
15). Equally, the radioactivity accumulation in the pancreas of the ani-
mals that had been exposed to streptozotocin, was approximately
one-half of that found in the pancreas of the controls (0.30% – 0.9
vs. 0.66% – 0.14 ID/g, respectively tStat = 4.94, df = 9).
The changes of islet zinc content occurred mainly on account
Figure 2. Comparison of Dithizone-[131I]-Histamine accumulation in the
selected tissues of normal rats (control, N = 6) and the recipients of
transplanted pancreatic islet cells (right testis graft, N = 5). 30 min p.i.v




of insulin-producing cells and in coincidence with glycemia chang-
es. It has been shown that selective damage of insulin producing
cells, phase glycemic fluctuations and permanent diabetes devel-
opment are connected with chelator zinc binding in the lysosome-
segregation apparatus of these cells (7). The insulin producing cells
were devoid of zinc in diabetes of long duration with high hypergly-
cemia, and it is supposed that diabetogenic-chelating agents are
capable of producing irreversible diabetogenic affection in those
beta-cells that contain a critical concentration of reactant zinc (8).
Dithizone is a recognised diabetogenic agent in vivo, howev-
er, under controlled conditions (concentration and solvent used),
it can play a useful role as a supravital stain for identification of
islets to be used for transplantation, as well as ex vivo monitoring
agent of viability of transplanted islets (13, 9, 10). The unique
mechanism of dithizone action in the interior of the viable pancre-
atic islet suggests the possible development of a specific radiop-
harmaceutical that may have potential clinical application in the
diagnosis of the pancreatic organ allografts or the islets rejection.
It seems promising that the strategy described above may be
acquired by application of the radioactive analogue of dithizone
i.e. Dithizone-[131I]-Histamine conjugate. Both the colour and the
radioactivity of the islets exposed to the conjugate confirm the
transporting of the conjugate through the lipid membrane to the
interior of islets, and suggest the specific mechanism of the con-
jugate action in the interior of the islets. Likewise, the indication of
a positive staining and radioactive labelling of the islet cells both
in vitro and in the testis graft, suggest that the radioactive ana-
logue of dithizone, i.e. the Dithizone-[*I]-Histamine conjugate may
be a promising diagnostic agent for detecting the viability of trans-
planted pancreas or the islets by radioisotope scanning tech-
niques. However, regarding a low radioactivity level detected in
the graft, further expanded studies using bigger animal transplan-
tation models and a greater amount of transplanted islet cells
should be undertaken.
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